Collectively, the data indicated that the blockade of DAG/PKCδ and CaMK IIβ down-regulated cell migration of gastric adenocarcinoma cells, as well as the effect of PLCγ1 inhibition. This evidence concerns the gene CAMK2B and gastric adenocarcinoma.